UNTIL ALL SURVIVE.
We believe in a world where Cancer Outliers become the blueprint for curing everyone because miracles should happen to all, until all survive.
Cure51 is co-founded with worldwide leading oncology centers
OUR MISSION
Cure51 focuses on extraordinary patients.
the Exception
that proves
the rule.
Our exceptional survivor community is a living proof that nature can beat Cancer.



Camille, USA

Jean-Luc, France

Yann, France

Samantha, USA

Maria, Chile


Catherine, France
OUR NETWORK
OUR SCIENTIFIC LEADERS
Our Scientific Steering Committee
includes world-renowned oncologists
JOSEP TABERNERO, MD, PhD
Director Vall d’Hebron Institute of Oncology, Barcelona
FABRICE ANDRÉ, MD, PhD
President Elect ESMO Research Director Institut Gustave Roussy, Villejuif
OLIVIER ELEMENTO, PhD
Director of Englander Institute for Precision Medicine at Cornell University, NY
LOUIS DE MESTIER, MD
Principal Investigator Hopital Beaujon, AP-HP, Paris
PAN-CHYR YANG, MD, PhD
Principal Investigator National Taiwan University Hospital (NTUH)
NELSON DUSETTI, PhD
Research Director, INSERM | Pancreatic Cancer & Translational Oncology
SCOTT KOPETZ, MD
Head of Colorectal Cancer Moonshot programs MD Anderson, Houston
SOLANGE PETERS, MD, PhD
Head of Medical Oncology CHUV Lausanne
ULRICH KEILHOLZ, MD, PhD
LEAD SCLC, Director Charité Comprehensive Cancer Center Berlin
JEAN-YVES BLAY, MD, PhD
President UniCancer & Director Centre Léon Bérard, Lyon